International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Optimisation and Evaluation of Opthalmic Gel containing Solid Nanoparticles loaded with Ciprofloxacin
| Author(s) | Ms. Nidhi Rajput |
|---|---|
| Country | India |
| Abstract | Delivering drugs to the eye remains difficult because numerous anatomical and physiological defenses limit how long therapeutic agents stay on the ocular surface and how effectively they pass through surrounding tissues. Ciprofloxacin hydrochloride, a commonly prescribed antibiotic for bacterial infections of the eye, is an example of a drug whose effectiveness is reduced when administered in traditional drop formulations, largely due to rapid clearance and limited absorption. Recent developments in nanotechnology are opening new possibilities for overcoming these constraints. In particular, combining solid lipid nanoparticles (SLNs) with in-situ gelling systems has emerged as a promising strategy for extending ocular residence time and improving drug penetration. SLNs can protect the drug, regulate its release, and enhance its interaction with the corneal surface, while in-situ gels transform into a more viscous form upon contact with the eye’s natural environment, helping the formulation remain in place longer. Embedding ciprofloxacin-loaded SLNs within such a gel formulation may increase the drug’s therapeutic impact, allow for fewer daily administrations, and potentially improve patient adherence to treatment. This integrated delivery platform represents an innovative direction for managing bacterial ocular infections and may offer meaningful advantages for future ocular drug-delivery research. |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 6, November-December 2025 |
| Published On | 2025-12-09 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i06.62981 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals